Calyxt
Agbiotech company focused on developing crops with healthier characteristics.
Launch date
Employees
Market cap
$124m
Enterprise valuation
$124m (Public information from Sep 2024)
Share price
$17.59 CLXT
Roseville Minnesota (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 24.0m | 26.0m | <1m | 1.8m | 2.1m | 8.3m | 45.2m |
% growth | 243 % | 8 % | (99 %) | 1057 % | 17 % | 294 % | 441 % |
EBITDA | (32.0m) | (25.0m) | (16.8m) | (48.7m) | (71.9m) | (69.5m) | (38.6m) |
% EBITDA margin | (133 %) | (96 %) | (10726 %) | (2679 %) | (3396 %) | (833 %) | (85 %) |
Profit | (45.0m) | (29.0m) | (17.0m) | (268m) | (93.6m) | (95.4m) | (80.7m) |
% profit margin | (188 %) | (112 %) | (10828 %) | (14728 %) | (4420 %) | (1144 %) | (179 %) |
EV / revenue | 6.1x | 3.1x | 45.9x | 204.8x | 72.4x | 18.4x | 3.4x |
EV / EBITDA | -4.6x | -3.3x | -0.4x | -7.6x | -2.1x | -2.2x | -4.0x |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
N/A | $477k | Grant | |
N/A | N/A | IPO | |
N/A | $60.9m | Post IPO Equity | |
* | N/A | Acquisition | |
Total Funding | $477k |
Related Content
Recent News about Calyxt
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.